Repros Therapeutics, Inc. (RPRX) Posts Narrower than Expected Q3 Loss
Get Alerts RPRX Hot Sheet
Join SI Premium – FREE
Repros Therapeutics, Inc. (NASDAQ: RPRX) reported Q3 loss of ($0.32), $0.03 better than the analyst estimate of ($0.35).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Deere & Co. (DE) Tops Q2 EPS by 66c; Cuts net income forecast
- Royalty Pharma to Present at Upcoming Investor Conferences
- Aileron Therapeutics (ALRN) Tops Q1 EPS by 16c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!